These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1131461)

  • 1. New particle counter for nondestructive monitoring of parenterals.
    Porter MC
    Bull Parenter Drug Assoc; 1975; 29(4):169-82. PubMed ID: 1131461
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of particle contamination of solutions for pharmaceutical use: selection of a suitable method.
    Lotteau P
    J Parenter Sci Technol; 1990; 44(6):302-5. PubMed ID: 2277317
    [No Abstract]   [Full Text] [Related]  

  • 3. [Microbiological in-process control in drug manufacture].
    Seyfarth VH
    Arzneimittelforschung; 1985; 35(1A):205-16. PubMed ID: 4039162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleanliness assessment of supplier-cleaned stoppers.
    Townsend MW; Conti B; Hazrati A; DeLuca PP
    J Parenter Sci Technol; 1989; 43(2):98-102. PubMed ID: 2709242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of improved standardization methods and instrumentation in the USP particulate test for SVI.
    Barber TA; Lannis MD; Williams JG; Ryan JF
    J Parenter Sci Technol; 1990; 44(4):185-203. PubMed ID: 2213427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Devices for use in pharmaceutical filling machines to reduce the presence of particles glass in glass ampules].
    Lencioni E; Franchi G; Reghini A; Pezzuoli G
    Boll Chim Farm; 1983 Jan; 122(1):10-9. PubMed ID: 6882528
    [No Abstract]   [Full Text] [Related]  

  • 7. Quality control of absolute bacteria removal filters.
    Pall DB
    Bull Parenter Drug Assoc; 1975; 29(4):192-204. PubMed ID: 1131463
    [No Abstract]   [Full Text] [Related]  

  • 8. Particulate matter counting: the technical issues.
    Knapp JZ
    J Parenter Sci Technol; 1988; 42(1):2-8. PubMed ID: 3361403
    [No Abstract]   [Full Text] [Related]  

  • 9. [The microbiology of medication: concept - elaboration - control].
    Lagodsky H; Blanchard JC; Jandard M; Migne J
    Biol Med (1971); 1973 Dec; 2(2):141-56. PubMed ID: 4807318
    [No Abstract]   [Full Text] [Related]  

  • 10. Aseptic methods for removing fluids from small-volume parenterals.
    Nagata RE; Mock ED; Reynolds G; Moriyama W; Schalker WL
    Hosp Pharm; 1977 Mar; 12(3):118-9, 122-6. PubMed ID: 10235811
    [No Abstract]   [Full Text] [Related]  

  • 11. Design and operation of an in-house pyrogen test facility.
    Armistead RL; Taylor NL
    Bull Parenter Drug Assoc; 1977; 31(1):14-7. PubMed ID: 831894
    [No Abstract]   [Full Text] [Related]  

  • 12. [Microbiological aspects of the pharmaceutical environment].
    Buogo A; Guerrato G; Giulioni A; Papakristo G
    Boll Chim Farm; 1979 Jan; 118(1):9-17. PubMed ID: 454532
    [No Abstract]   [Full Text] [Related]  

  • 13. [Demand for modern distillation equipment].
    Shvedov IuA; Frosin VN; Belova OI
    Med Tekh; 1975; (2):38-41. PubMed ID: 1226095
    [No Abstract]   [Full Text] [Related]  

  • 14. [Device for the intrapharmacy visual control of solutions for mechanical contaminations].
    Zhurko VV; Meerkop GE; Besedina IV
    Farmatsiia; 1980; 29(2):59-60. PubMed ID: 7380041
    [No Abstract]   [Full Text] [Related]  

  • 15. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
    [No Abstract]   [Full Text] [Related]  

  • 16. Sterilizing filtration of liquids. Technical report no. 26 (revised 2008).
    Antonsen HR; Awafo V; Bender JL; Carter JR; Conway RS; Egli S; Feeser TM; Jornitz MW; Kearns M; Levy RV; Madsen RE; Martin JM; McBurnie LD; Meissner LS; Meltzer TH; Pawar V; Phelan M; Stinavage PS; Sweeney N; Vega H; Witchey-Lakshmanan LC;
    PDA J Pharm Sci Technol; 2008; 62(5 Suppl TR26):2-60. PubMed ID: 19642423
    [No Abstract]   [Full Text] [Related]  

  • 17. [Problems of control of polymers used in drug technology].
    Krówczyński L
    Polim Med; 1984; 14(1-4):5-12. PubMed ID: 6533635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Purity requirements for drugs].
    Battaglino G
    Ann Ist Super Sanita; 1982; 18(4):615-20. PubMed ID: 7188516
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of the Reorganization of Drug Legislation "Act" on the production and admission of infusion solutions].
    Mohrbutter K; Schnieders B; Schuster J; Wolff U
    Klin Anasthesiol Intensivther; 1977; (14):74-88. PubMed ID: 926693
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bioengineering, pharmaceutical development and control of contamination: the three components of pharmaceutical engineering and their influence in advanced methods of production].
    Ghirardini M; Falini R
    Boll Chim Farm; 1986 Sep; 125(9):328-38. PubMed ID: 3828099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.